GlassScriptPhysician profile
Ronald Poblete
NPI 1740271998
$26,450.28
in general payments reported to CMS, 2019-2025
18 companies · $2,447 in 2025
The $2,447 reported for 2025 was more than what 87% of Infectious Disease providers received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,050 · 2020: $1,160 · 2021: $7,494 · 2022: $5,565 · 2023: $1,729 · 2024: $2,006 · 2025: $2,447.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,182.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $13,374.61 | 2019-2025 | Dovato, Cabenuva, Apretude |
| Gilead Sciences, INC. | $8,296.20 | 2019-2025 | Biktarvy, Yeztugo |
| Theratechnologies INC. | $1,448.61 | 2019-2025 | Egrifta, Trogarzo, Egrifta Sv |
| Merck Sharp & Dohme LLC | $951.44 | 2019-2025 | Pifeltro, Delstrigo, Dificid |
| Janssen Biotech, INC. | $887.20 | 2019-2023 | Symtuza |
| Janssen Products, LP | $462.95 | 2019-2022 | |
| Abbvie INC. | $282.01 | 2022-2025 | |
| Napo Pharmaceuticals INC | $179.10 | 2019-2025 | Mytesi |
| Emd Serono, INC. | $173.33 | 2019-2025 | Serostim |
| Welch Allyn | $164.74 | 2021 | |
| Baxter Healthcare | $109.82 | 2022 | |
| Janssen Scientific Affairs, LLC | $62.18 | 2020-2022 | |
| Biogen, INC. | $26.83 | 2021 | |
| Insmed, INC. | $16.26 | 2024 | Arikayce |
| Pfizer INC. | $15.00 | 2022 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Poblete listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.